Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia
- 30 June 1995
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 17 (3) , 402-412
- https://doi.org/10.1016/0149-2918(95)80105-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Five-Factor Model of Schizophrenia Initial ValidationJournal of Nervous & Mental Disease, 1994
- Risperidone in the treatment of schizophreniaAmerican Journal of Psychiatry, 1994
- Changes in Single Symptoms and Separate Factors of the Schizophrenic Syndrome after Treatment with Risperidone or HaloperidolPharmacopsychiatry, 1994
- Principal component analysis of the Swedish version of the Positive and Negative Syndrome Scale for schizophreniaNordic Journal of Psychiatry, 1993
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987
- Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal SyndromesArchives of General Psychiatry, 1983
- Prevention of Relapse in SchizophreniaArchives of General Psychiatry, 1980
- Fluphenazine and Social Therapy in the Aftercare of Schizophrenic PatientsArchives of General Psychiatry, 1979
- Drug and Sociotherapy in the Aftercare of Schizophrenic PatientsArchives of General Psychiatry, 1974
- The Prediction of Outcome in SchizophreniaArchives of General Psychiatry, 1972